Curated coverage for pharmaceuticals with top developments, timeline context, and connected threads.
Europe gets 70-80% of its generic medicine from India. The US pharmaceutical tariff threat and India's own policy changes are creating supply chain risks that European health ministries are quietly worried about.
EuroBulletin24 Editorial Desk | Linked source
The Trump administration has signaled pharmaceutical tariffs could reach 200% by mid-to-late 2026. Here is what would happen to the price of medicines for American patients and globally.